Human immunodeficiency virus type 1 Nef protein sensitizes CD4+ T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95 ligand pathway

被引:99
作者
Zauli, G
Gibellini, D
Secchiero, P
Dutartre, H
Olive, D
Capitani, S
Collette, Y
机构
[1] Univ Ferrara, Dept Morphol & Embryol, Human Anat Sect, I-44100 Ferrara, Italy
[2] Univ Bologna, Inst Microbiol, Bologna, Italy
[3] Univ Maryland, Inst Human Virol, Baltimore, MD 21201 USA
[4] Univ Mediterrainee, INSERM, U119, Marseille, France
关键词
D O I
10.1182/blood.V93.3.1000.403a12_1000_1010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Many viruses have evolved genes encoding proteins that regulate cell death by apoptosis. The human immunodeficiency virus type 1 (HIV-1) Nef protein alters T-cell development and signaling and is required for optimal viral replication and pathogenicity in vivo. To analyze the interference of Nef with cell survival, we used both regulated and constitutively expressed nef alleles in stably transfected T-cell lines. Nef-expressing cells were sensitized to cell death by apoptosis, which was specifically exacerbated by an anti-CD95 IgM monoclonal antibody (MoAb). Flow cytometric analysis showed that the surface expression of both CD95 and CD95 ligand (CD95L) was upregulated by endogenous Nef expression. Nef-mediated apoptosis was almost completely suppressed by the addition in culture of an anti-CD95 Fab' IgG MoAb, which specifically blocks CD95/CD95L interactions, Lastly, mutation of a proline motif in the core region of the nef gene, which disrupts its ability to interact with cellular kinases and reduces HIV-1 replication in vitro, completely abrogated the Nef-mediated induction of apoptosis as well as its ability to upregulate surface CD95 and CD95L. These findings may provide molecular insight into the role of endogenous Nef in the T-cell depletion observed in vivo, particularly HIV-specific cytotoxic CD8(+) T cells. (C) 1999 by The American Society of Hematology.
引用
收藏
页码:1000 / 1010
页数:11
相关论文
共 65 条
  • [1] FAS LIGAND MEDIATES ACTIVATION-INDUCED CELL-DEATH IN HUMAN T-LYMPHOCYTES
    ALDERSON, MR
    TOUGH, TW
    DAVISSMITH, T
    BRADDY, S
    FALK, B
    SCHOOLEY, KA
    GOODWIN, RG
    SMITH, CA
    RAMSDELL, F
    LYNCH, DH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) : 71 - 77
  • [2] Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice
    Aldrovandi, GM
    Zack, JA
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (03) : 1505 - 1511
  • [3] T-CELL RECEPTOR-INDUCED FAS LIGAND EXPRESSION IN CYTOTOXIC T-LYMPHOCYTE CLONES IS BLOCKED BY PROTEIN-TYROSINE KINASE INHIBITORS AND CYCLOSPORINE-A
    ANEL, A
    BUFERNE, M
    BOYER, C
    SCHMITTVERHULST, AM
    GOLSTEIN, P
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (10) : 2469 - 2476
  • [4] Upregulation of fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes
    Badley, AD
    McElhinny, JA
    Leibson, PJ
    Lynch, DH
    Alderson, MR
    Paya, CV
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (01) : 199 - 206
  • [5] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF PROTEIN DOWN-REGULATES TRANSCRIPTION FACTORS NF-KAPPA-B AND AP-1 IN HUMAN T-CELLS IN-VITRO AFTER T-CELL RECEPTOR STIMULATION
    BANDRES, JC
    RATNER, L
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (05) : 3243 - 3249
  • [6] The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase
    Baur, AS
    Sass, G
    Laffert, B
    Willbold, D
    ChengMayer, C
    Peterlin, BM
    [J]. IMMUNITY, 1997, 6 (03) : 283 - 291
  • [7] HIV-1 NEF LEADS TO INHIBITION OR ACTIVATION OF T-CELLS DEPENDING ON ITS INTRACELLULAR-LOCALIZATION
    BAUR, AS
    SAWAI, ET
    DAZIN, P
    FANTL, WJ
    CHENGMAYER, C
    PETERLIN, BM
    [J]. IMMUNITY, 1994, 1 (05) : 373 - 384
  • [8] SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1
    Briggs, SD
    Sharkey, M
    Stevenson, M
    Smithgall, TE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (29) : 17899 - 17902
  • [9] Chung CD, 1997, J IMMUNOL, V159, P1758
  • [10] Collette Y, 1996, J IMMUNOL, V156, P360